Intracardiac Thrombosis Due to Antiphospholipid Syndrome
Authors : Nurullah Tüzün, Efe Edem, Mustafa Türker Pabuccu
Pages : 201-203
View : 19 | Download : 8
Publication Date : 2016-12-01
Article Type : Other
Abstract :Normal 0 false false false TR JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:Cambria; mso-ascii-font-family:Cambria; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Cambria; mso-hansi-theme-font:minor-latin;} Antiphospholipid syndrome (APS) is an autoimmune disease characterised by arterial and venous thrombosis. Recurrent thrombosis and pregnancy losses are important in its diagnosis. Due to the risk of recurrence of thrombosis, long-term anticoagulant treatment may be required. Here, we present the case of a patient who suffered from intracardiac thrombosis due to APS. At present, treatment for significant thrombotic events in patients with APS, such as the aforementioned intracardiac thrombosis, is generally lifelong.Keywords : Antiphospholipid syndrome, intracardiac thrombosis